Contents
Contents
In the Halifax physician bonus Stark settlement, Halifax Hospital Medical Center and Halifax Staffing agreed to pay $85 million to resolve allegations that their physician contracts generated improper Medicare claims. The government alleged that oncology bonuses counted the value of prescription drugs and tests the doctors ordered. For someone who works with physician pay, that is the detail that matters: a treatment decision could also feed the doctor’s bonus.
The Justice Department announced the settlement on March 11, 2014. The case against the Daytona Beach, Florida hospital system began with a qui tam complaint from Halifax Staffing’s director of physician services. The Justice Department’s Civil Division, the U.S. Attorney’s Office for the Middle District of Florida and the health department’s inspector general conducted the investigation and litigation. The case connects physician compensation to the orders and hospital bills that someone inside the business could recognize together.
The government alleged that Halifax’s contracts with six medical oncologists included incentive bonuses based in part on the value of prescription drugs and tests they ordered and Halifax billed to Medicare. We see a basic conflict in the alleged arrangement: the doctor deciding what a patient needed could benefit from the value of the resulting order.
The hospital and staffing company had different roles in that payment chain. In its later account of the case, the U.S. Attorney’s Office described the whistleblower’s allegation that the hospital created a staffing company to employ most hospital employees and paid it the exact cost of their salaries and benefits. Physicians allegedly received a base salary and a bonus tied to a percentage of their billings and, in some instances, profits from particular hospital departments.
Professional billing and hospital facility billing remain distinct even when the hospital employs the physician. A compensation worksheet can connect them by counting hospital revenue toward physician pay.
The government also alleged that Halifax paid three neurosurgeons more than the fair market value of their work. That allegation concerned the amount paid for their services, alongside the oncology allegation about what revenue counted toward a bonus. The intervention announcement described contracts allegedly paying above fair market value, lacking commercial reasonableness or taking account of the volume or value of referrals.
Research on physician self-referral explains why revenue beyond the physician’s own work deserves attention. The Robert Wood Johnson Foundation’s 2008 report, Physician Self-Referral and Physician-Owned Specialty Facilities, found strong evidence that self-referral increased the use of health care services, with indirect evidence that some of the increase was medically inappropriate.
The report identified the ability to earn from services that require little extra physician time as a financial incentive. In its discussion of physician-owned facilities, it put the distinction plainly:
However, it requires little extra time for a physician to receive a share of profits generated by facility fees paid to hospitals or ASCs, or from the technical fee component of imaging services.
Halifax’s case concerned employment contracts, and the government alleged a specific connection between ordered services and compensation. That financial incentive explains why we look beyond the salary line: what else earns money for the physician when an order becomes a bill?
On November 13, 2013, the U.S. District Court for the Middle District of Florida ruled that Halifax’s oncology contracts violated the Stark Law. Halifax later settled the government’s remaining claims over physician compensation and Medicare billing.
The physician self-referral issue reached Medicare through the hospital’s bills. The government said Halifax submitted claims for services referred under improper financial relationships with its physicians. For an employee who knows the contracts, the significance is the connection between the compensation terms and the services the hospital charged to the public program.
At Tuomey, the government alleged that specialist compensation included a portion of hospital facility revenue generated by referrals. The jury found Stark violations and false Medicare claims. Tuomey later settled the False Claims Act judgment against it. Both cases put physician pay beside the hospital revenue it could generate.
The Justice Department announced a $20.8 million whistleblower reward as a share of the physician-compensation settlement. Its earlier announcement identified the employee who brought the case as the director of physician services and explained that the government joined only part of the allegations.
A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers. In Halifax, the announced award belonged to the physician-compensation settlement that the government pursued.
The U.S. Attorney’s Office later reported a separate $1 million settlement of the whistleblower’s medical-necessity and upcoding claims, reached with the government’s consent. Those allegations concerned medically unnecessary spine surgeries billed to Medicare and patient admissions billed above the proper level of service. The whistleblower pursued that part of the case after the government joined the Stark claims.
The compensation allegations asked how doctors were paid in relation to the business they generated. The separate allegations asked whether the spine surgery was medically necessary and whether admission bills claimed too high a level of service. Someone working with contracts could see one part, while someone working with clinical records or admission billing could recognize another.
Halifax also agreed to a corporate integrity agreement with the Department of Health and Human Services Office of Inspector General. The settlement announcement described substantial internal compliance reforms and independent review of federal healthcare program claims for five years.
The agreement also required a legal reviewer to monitor provider arrangements and a compliance expert to assist the board, both reporting regularly to the inspector general. We see the same connection in those obligations as in the allegations: the physician contracts and the government bills needed scrutiny together.
For an insider, the useful connection runs from the compensation agreement to the revenue in the bonus calculation, then to the physician’s orders and the hospital’s bills. The Halifax allegations give that comparison a concrete subject: drugs and tests counted toward oncology bonuses, and payments to neurosurgeons that the government alleged exceeded the value of their work.
We examine the relationship between compensation records, orders and claims with you. An agreement can show what the employer promised to pay, while a bonus worksheet can show which revenue actually drove the calculation. For a reader considering a physician-practice whistleblower case, knowing why those records fit together is valuable expertise to bring to the conversation.
If you know which drug orders, tests or hospital revenues went into physician pay, talk with our whistleblower experts about the arrangement you saw. We work alongside you to connect the compensation decisions to the Medicare claims and bring in healthcare fraud whistleblower lawyers who understand physician referral cases. Your knowledge of how the hospital actually paid its doctors is where we start building your strongest physician referral whistleblower case, with us beside you throughout.